Evidence map›Paper›PMID 40493092›Full record

ArticleDiscover oncology2025

LncRNA ZFAS1 promotes the transformation from prostatitis to prostate cancer via myddosome assembly-mediated activation of NF-κB signaling.

Tao Feng, Hao Shen, Shenglan Ye

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tao FengDepartment of Urology Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
Hao ShenDepartment of Medical Administration, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
Shenglan YeDepartment of Respiratory Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, No.26 Shengli Street, Jiang 'an District, Wuhan, 430014, China. oswalt771125@163.com.

Funding

Natural Science Foundation of Hubei Province 2022CFC036Teaching and research project of Wuhan municipal colleges and universities 2021019
6 · The paper itself

Abstract

backgroundProstatitis is a critical factor in promoting carcinogenesis, but the key molecular mechanisms remain unknown. Long noncoding RNA (lncRNA) ZFAS1 was reported to be involved in the development of human cancers including prostate cancer and some inflammatory diseases. This research aims at investigating the function of ZFAS1 in regulating prostatitis to prostate cancer transformation and the underlying mechanism.

methodsA prostatitis-cancer transformation cell model RWPE-1/THP-1 was established by co-culturing human prostate epithelial cells RWPE-1 with human acute monocytic leukemia cells THP-1. CCK-8, colony formation, and flow cytometry assays were used to detect the effects of ZFAS1 knockdown or overexpression on the proliferation and apoptosis and malignant transformation ability of the model cells. The influence of ZFAS1 knockdown on the levels of apoptosis-related proteins, MyD88 protein aggregation in cell lysate and pellet fractions, and the phosphorylation of IKKβ, IκBα, and NF-κB p65 in RWPE-1/THP-1 cells. Immunofluorescence staining was used to detect NF-κB p65 nuclear translocation in RWPE-1/THP-1 cells. ST2825 was used to further confirm whether ZFAS1 affects prostatitis to prostate cancer transformation by regulating NF-κB pathway through modulating MYD88 dimerization and the subsequent myddosome assembly.

resultsZFAS1 expression was markedly increased in RWPE-1/THP-1 cells. ZFAS1 silencing repressed the proliferation and facilitated the apoptosis of RWPE-1/THP-1 cells. P-IKKβ, p-IκBα and p-p65 protein levels and NF-κB p65 nuclear translocation were significantly enhanced in RWPE-1/THP-1 cells, which were reversed by ZFAS1 knockdown. ZFAS1 knockdown exerted the same inhibitory effects as ST2825 treatment on the degree of MyD88 aggregation and NF-κB pathway activation in RWPE-1/THP-1 cells, suggesting that ZFAS1 knockdown inactivated the NF-κB pathway in RWPE-1/THP-1 cells through suppressing MYD88 dimerization and the subsequent myddosome assembly. In addition, ST2825 treatment overturned the influence of ZFAS1 overexpression on the proliferation and apoptosis of RWPE-1/THP-1 cells.

conclusionZFAS1 promotes prostatitis to cancer transformation by activating the NF-κB signaling through promoting MYD88 dimerization and the subsequent myddosome assembly.

Indexed as

Malignant transformationMYD88Myddosome assemblyNF-κBProstate cancerProstatitisZFAS1

Identifiers

PMID40493092
PMCPMC12151982

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.